Predictive and prognostic biomarkers can be an attractive strategy for stratifying patients who are likely to benefit from treatment. Our noninvasive biomarkers can do just that and much more. In addition, we have a novel serum biomarker for calprotectin that is extremely popular for clinical programs in inflammatory bowel diseases such as Ulcerative Colitis and Crohn's Disease.

More about our biomarkers for IBD

Find publications

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.